Delayed onset congenital hypothyroidism in a patient with DUOX2 mutations and maternal iodine excess

Toshihiko Kasahara1, Satoshi Narumi, Keisuke Okasora

  • 1Department of Pediatrics, Higashitoyonaka Watanabe Hospital, Osaka, Japan.

Insights

Delayed-onset congenital hypothyroidism (CH) can occur due to genetic defects and environmental factors like excess iodine. This case highlights how these factors can impact newborn screening for CH.

Area of Science:

  • Endocrinology
  • Genetics
  • Environmental Health

Background:

  • Congenital hypothyroidism (CH) is a common endocrine disorder.
  • Newborn screening diagnoses most CH cases, enabling early intervention and preventing intellectual disability.
  • However, some CH cases present with delayed onset, evading newborn screening.

Observation:

  • A patient presented with delayed-onset CH despite a negative newborn screening result.
  • The patient had both a genetic defect (DUOX2 mutations) and in utero iodine excess (maternal seaweed consumption).
  • Overt CH developed at 3 months, resolving by age 3 with thyroxine supplementation, indicating transient CH.

Findings:

  • This case demonstrates a dual etiology for CH: a DUOX2 genetic mutation and environmental iodine excess.
  • The combination of genetic predisposition and environmental factors masked CH during newborn screening.
  • The patient experienced transient CH, emphasizing the phenotypic variability of genetic CH defects.

Implications:

  • Environmental factors can significantly modify the phenotype of genetic CH, potentially leading to false-negative newborn screening results.
  • This case underscores the importance of considering environmental exposures in diagnosing and managing CH.
  • Further research is needed to understand the interplay between genetic and environmental factors in CH pathogenesis and screening accuracy.

Related Concept Videos

Hypothyroidism II: Pathophysiology01:23

Hypothyroidism II: Pathophysiology

Hypothyroidism is a disorder characterized by insufficient production of thyroid hormones, which regulate metabolism, energy balance, and multiple organ systems.TypesHypothyroidism is classified based on the level of dysfunction. Primary hypothyroidism results from intrinsic thyroid gland dysfunction, causing reduced hormone production despite normal or increased stimulation. Secondary hypothyroidism arises from inadequate thyroid-stimulating hormone (TSH) secretion by the pituitary. Tertiary...
Hyperthyroidism I: Introduction01:25

Hyperthyroidism I: Introduction

Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...
Hyperthyroidism II: Pathophysiology01:27

Hyperthyroidism II: Pathophysiology

Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...
Goiter01:27

Goiter

Goiter refers to an abnormal enlargement of the thyroid gland that may appear as a diffuse goiter (uniform enlargement) or nodular (single or multiple nodules). Functionally, it is classified as nontoxic (normal/low hormone levels) or toxic (excess hormone production).PathophysiologyDiffuse thyroid enlargement typically results from prolonged stimulation by thyroid-stimulating hormone (TSH) or TSH-like agents, commonly seen in hypothyroidism or iodine deficiency. In contrast, in hyperthyroid...
Synthesis and Regulation of Thyroid Hormones01:20

Synthesis and Regulation of Thyroid Hormones

Low blood levels of the thyroid hormones — triiodothyronine (T3) and thyroxine (T4) — signal the hypothalamus to release the thyrotropin-releasing hormone (TRH). TRH then reaches the pituitary gland and stimulates the release of thyroid-stimulating hormone(TSH) into the bloodstream.
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The iodine is then...
Graves Disease II: Pathophysiology01:24

Graves Disease II: Pathophysiology

Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor, and heat...